(Q36153306)

English

Systematic review of effectiveness of bisphosphonates in treatment of low bone mineral density and fragility fractures in juvenile idiopathic arthritis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

1 reference

Europe PubMed Central

Systematic review of effectiveness of bisphosphonates in treatment of low bone mineral density and fragility fractures in juvenile idiopathic arthritis (English)

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

juvenile rheumatoid arthritis

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Deborah P.M. Symmons

object named as

D Symmons

6

0 references

author name string

J Thornton

1

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

D M Ashcroft

2

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

M Z Mughal

3

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

R A Elliott

4

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

T W O'Neill

5

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

language of work or name

0 references

publication date

11 May 2006

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Archives of Disease in Childhood

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

91

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

9

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

753-761

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

2 October 2017

Bisphosphonate treatment of bone disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

2 October 2017

Pamidronate treatment of less severe forms of osteogenesis imperfecta in children.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

2 October 2017

Intravenous pamidronate treatment of children under 36 months of age with osteogenesis imperfecta

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

2 October 2017

Short-term safety assessment in the use of intravenous zoledronic acid in children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

2 October 2017

Skeletal effects and functional outcome with olpadronate in children with osteogenesis imperfecta: a 2-year randomised placebo-controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

2 October 2017

Intravenous pamidronate treatment in children with moderate to severe osteogenesis imperfecta: assessment of indices of dual-energy X-ray absorptiometry and bone metabolic markers during the first year of therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

2 October 2017

Effectiveness of pretreatment in decreasing adverse events associated with pamidronate in children and adolescents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

2 October 2017

The role of bisphosphonates in diseases of childhood

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

2 October 2017

Low-dose intravenous pamidronate reduces fractures in childhood osteoporosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

2 October 2017

Bone densitometry in children assessed by dual x ray absorptiometry: uses and pitfalls

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

2 October 2017

Radiographic features of bisphosphonate therapy in pediatric patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

2 October 2017

Bone mass, size, and density in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

2 October 2017

The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

2 October 2017

Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

2 October 2017

Osteogenesis imperfecta: a new, early therapeutic approach with biphosphonates. A case report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

2 October 2017

Intravenous pamidronate in juvenile osteoporosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

2 October 2017

Effects of rheumatic disease and corticosteroid treatment on calcium metabolism and bone density in children assessed one year after diagnosis, using stable isotopes and dual energy x-ray absorptiometry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

2 October 2017

Bone mineral content and bone mineral metabolism: changes after growth hormone treatment in juvenile chronic arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

2 October 2017

Total-body bone mineral content in non-corticosteroid-treated postpubertal females with juvenile rheumatoid arthritis: frequency of osteopenia and contributing factors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

2 October 2017

Cyclic administration of pamidronate in children with severe osteogenesis imperfecta

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

2 October 2017

Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

2 October 2017

Treatment of children with Osteogenesis imperfecta in Estonia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

2 July 2018

Diagnosis of osteoporosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

2 July 2018

Long-term effects of bisphosphonates on the growing skeleton. Studies of young patients with severe osteoporosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

2 July 2018

Bisphosphonates in osteogenesis imperfecta

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

2 July 2018

Characteristics and bisphosphonate treatment of a patient with juvenile osteoporosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

2 July 2018

Treatment and prevention of osteoporosis in juvenile chronic arthritis with disodium clodronate.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

2 July 2018

Cyclical intravenous pamidronate treatment affects metaphyseal modeling in growing patients with osteogenesis imperfecta

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

23 September 2018

Effects of once-weekly oral alendronate on bone in children on glucocorticoid treatment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

23 September 2018

Pamidronate treatment of pediatric fracture patients on chronic steroid therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

23 September 2018

Radiological features of bisphosphonate therapy in children with osteogenesis imperfecta

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

23 September 2018

Delayed osteotomy but not fracture healing in pediatric osteogenesis imperfecta patients receiving pamidronate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

23 September 2018

Maternal and fetal outcome after long-term pamidronate treatment before conception: a report of two cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

23 September 2018

Biphosphonate-induced radiographic changes in two pediatric patients with rheumatic diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

23 September 2018

Respiratory distress with pamidronate treatment in infants with severe osteogenesis imperfecta

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

23 September 2018

Effect of pamidronate treatment on vertebral deformity in children with primary osteoporosis. A pilot study using radiographic morphometry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

23 September 2018

Oral clodronate as treatment of osteogenesis imperfecta

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

23 September 2018

Bisphosphonate-induced osteopetrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

23 September 2018

Treatment of osteoporosis and osteopenia in children--own experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

23 September 2018

Bisphosphonates, a new treatment for glucocorticoid-induced osteoporosis in children.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

23 September 2018

Rapid Increase in Grip Force After Start of Pamidronate Therapy in Children and Adolescents With Severe Osteogenesis Imperfecta

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

23 September 2018

Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III, and IV.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

23 September 2018

Treatment of symptomatic pediatric osteoporosis with cyclic single-day intravenous pamidronate infusions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

23 September 2018

Pamidronate treatment of severe osteogenesis imperfecta in a newborn infant.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

23 September 2018

Osteogenesis imperfecta types I, III, and IV: effect of pamidronate therapy on bone and mineral metabolism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

23 September 2018

Intravenous bisphosphonate therapy in children with osteogenesis imperfecta

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

23 September 2018

Effect of cyclical intravenous pamidronate therapy in children with osteogenesis imperfecta. Open-label study in seven patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

23 September 2018

Osteogenesis imperfecta and intravenous pamidronate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

23 September 2018

Changes in markers of bone turnover and inflammatory variables during alendronate therapy in pediatric patients with rheumatic diseases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

23 September 2018

Pamidronate treatment of osteogenesis imperfecta--lack of correlation between clinical severity, age at onset of treatment, predicted collagen mutation and treatment response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

23 September 2018

Cyclic pamidronate infusion improves bone mineralisation and reduces fracture incidence in osteogenesis imperfecta

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

23 September 2018

Efficacy of low dose schedule pamidronate infusion in children with osteogenesis imperfecta

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

23 September 2018

Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

23 September 2018

More broken bones: a 4-year double cohort study of young girls with and without distal forearm fractures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

23 September 2018

Assessment of bone mineral density in adults with a history of juvenile chronic arthritis: a cross-sectional long-term followup study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

23 September 2018

Weight-bearing physical activity, calcium intake, systemic glucocorticoids, chronic inflammation, and body constitution as determinants of lumbar and femoral bone mineral in juvenile chronic arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082926

23 September 2018

Treatment of osteogenesis imperfecta with the bisphosphonate olpadronate (dimethylaminohydroxypropylidene bisphosphonate)

1 reference

https://pubmed.ncbi.nlm.nih.gov/16690698

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous pamidronate treatment in osteogenesis imperfecta

1 reference

https://pubmed.ncbi.nlm.nih.gov/16690698

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beneficial effect of bisphosphonate during five years of treatment of severe osteogenesis imperfecta

1 reference

https://pubmed.ncbi.nlm.nih.gov/16690698

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous pamidronate treatment in osteogenesis imperfecta

1 reference

https://pubmed.ncbi.nlm.nih.gov/16690698

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone mineral density and turnover in children with systemic juvenile chronic arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16690698

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bisphosphonates in children with osteogenesis imperfecta may improve bone mineralization but not bone strength. Report of two patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/16690698

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Young adults with juvenile arthritis in remission attain normal peak bone mass at the lumbar spine and forearm

1 reference

https://pubmed.ncbi.nlm.nih.gov/16690698

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children: a prospective multicenter study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16690698

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteopenia in adults with a history of juvenile rheumatoid arthritis. A population based study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16690698

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Do bisphosphonates make children's bones better or brittle?

1 reference

https://pubmed.ncbi.nlm.nih.gov/16690698

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiological manifestations of bisphosphonate treatment with APD in a child suffering from osteogenesis imperfecta

1 reference

https://pubmed.ncbi.nlm.nih.gov/16690698

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is APD a promising drug in the treatment of severe osteogenesis imperfecta?

1 reference

https://pubmed.ncbi.nlm.nih.gov/16690698

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epi- and metaphyseal changes in children caused by administration of bisphosphonates

1 reference

https://pubmed.ncbi.nlm.nih.gov/16690698

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/16690698

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age

1 reference

https://pubmed.ncbi.nlm.nih.gov/16690698

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous administration of alendronate counteracts the in vivo effects of glucocorticoids on bone remodeling

1 reference

https://pubmed.ncbi.nlm.nih.gov/16690698

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regression of calcinosis during diltiazem treatment in juvenile dermatomyositis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16690698

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/ADC.2006.093997

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36153306&oldid=1631581173"